- Home
- TVRD vs NUW Comparison
TVRD vs NUW Comparison
Compare TVRD & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- NUW
- Stock Information
- Founded
- TVRD 2017
- NUW 2008
- Country
- TVRD United States
- NUW United States
- Employees
- TVRD N/A
- NUW N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- NUW Investment Managers
- Sector
- TVRD Health Care
- NUW Finance
- Exchange
- TVRD Nasdaq
- NUW Nasdaq
- Market Cap
- TVRD 246.5M
- NUW 245.0M
- IPO Year
- TVRD N/A
- NUW N/A
- Fundamental
- Price
- TVRD $25.77
- NUW $13.58
- Analyst Decision
- TVRD Strong Buy
- NUW
- Analyst Count
- TVRD 3
- NUW 0
- Target Price
- TVRD $60.67
- NUW N/A
- AVG Volume (30 Days)
- TVRD 56.7K
- NUW 45.3K
- Earning Date
- TVRD 05-13-2025
- NUW 01-01-0001
- Dividend Yield
- TVRD N/A
- NUW 3.66%
- EPS Growth
- TVRD N/A
- NUW N/A
- EPS
- TVRD N/A
- NUW N/A
- Revenue
- TVRD N/A
- NUW N/A
- Revenue This Year
- TVRD N/A
- NUW N/A
- Revenue Next Year
- TVRD N/A
- NUW N/A
- P/E Ratio
- TVRD N/A
- NUW N/A
- Revenue Growth
- TVRD N/A
- NUW N/A
- 52 Week Low
- TVRD $8.13
- NUW $12.45
- 52 Week High
- TVRD $34.31
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- NUW 47.87
- Support Level
- TVRD N/A
- NUW $13.55
- Resistance Level
- TVRD N/A
- NUW $13.69
- Average True Range (ATR)
- TVRD 0.00
- NUW 0.07
- MACD
- TVRD 0.00
- NUW 0.00
- Stochastic Oscillator
- TVRD 0.00
- NUW 38.89
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.